Company: STAA
Filing Date: 2025-09-16
Form Type: DEFM14A
Source: 0001193125-25-204396
Chunk: 13

Company: STAAR SURGICAL CO
Filing Date: 2025-09-16
Form: DEFM14A
Chunk 13
---
 documentary evidence of

-4-

your beneficial ownership of stock (such as a brokerage or securities account statement containing such information or a letter from a broker or other record holder of such shares confirming such
information) and a statement that such documentary evidence is a true and correct copy of what it purports to be, and provide an address at which you consent to receive notices given by the Surviving Corporation under Section 262 and to be set
forth on the verified list required by Section 262(f) of the DGCL.

Litigation Relating to the Merger

In connection with the Merger Agreement, an individual lawsuit has been filed by a purported stockholder of STAAR in the United States District
Court for the Central District of California, captioned Carterv. STAAR Surgical Company et al., 8:25-cv-01993 (filed September 5, 2025) (the “Complaint”). The Complaint generally alleges that the preliminary proxy
statement filed on August 29, 2025 in connection with the Merger Agreement (the “Preliminary Proxy”) misrepresents and/or omits certain purportedly material information. The Complaint asserts violations of Sections 14(a) and 20(a) of the
Exchange Act and Rule 14a-9 promulgated thereunder against STAAR and the members of the STAAR Board. The Complaint seeks, among other things: an injunction enjoining the consummation of the Merger; rescission or rescissory damages in the event
the Merger is consummated; direction that defendants cause a revised proxy statement to be disseminated; costs of the action, including plaintiffs’ attorneys’ fees and experts’ fees; and other relief the court may deem just and
proper. In addition to the Complaint, several purported stockholders of STAAR sent demand letters (the “Demands,” and together with the Complaint, the “Matters”) alleging similar deficiencies regarding the disclosures made in
the Preliminary Proxy.

STAAR cannot predict the outcomes of the Matters, but believes that the Matters are without merit. If additional
similar complaints are filed or demands are received by STAAR, absent new or significantly different allegations, STAAR will not necessarily disclose such additional filings or demands.

Regulatory Approvals Required for the Merger

The consummation of the Merger is subject to the Hart-Scott-Rodino Antitrust Improvements Act of 1976, as amended, and the rules and
regulations promulgated